Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: A review

MCN The American Journal of Maternal/Child Nursing

Volumn 33, Issue 6, 2008, Pages 355-361

  Fleschler, Robin ^a   Peskin, Melissa F ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Childbearing; Depression; Pregnancy; SSRIs

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; AFFECTIVE PSYCHOSIS; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; PSYCHOLOGICAL ASPECT; REVIEW;

ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; SEROTONIN UPTAKE INHIBITORS;

EID: 59849125644     PISSN: 0361929X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NMC.0000341255.80426.7b     Document Type: Article

References (34)

1. Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007). Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. New England Journal of Medicine, 356, 2684-2692.
2. American Academy of Pediatrics (2001). The transfer of drugs and other chemicals into human milk. Pediatrics, 108, 776-789.
3. American College of Obstetricians and Gynecologists (ACOG). (2006). Committee opinion: Treatment with selective serotonin reuptake inhibitors during pregnancy. Obstetrics & Gynecology, 108, 1601-1603.
4. American College of Obstetricians and Gynecologists (ACOG). (2008). Practice bulletin: Use of psychiatric medications during pregnancy and lactation. Obstetrics & Gynecology, 111, 1001-1120.
5. Bérard, A., Ramos, É., Rey, É., Blais, L., St.-André, M., & Oraichi, D. (2007). First trimester exposure to paroxetine and risk of cardiac malformations in infants: The importance of dosage. Birth Defects Research (Part B), 80, 18-27.
6. Berle, J. O., Steen, V. M., Aamo, T. O., Breilid, H., Zahlsen, K., & Spigset, O. (2004). Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: Infant exposure, clinical symptoms, and cytochrome p450 genotypes. Journal of Clinical Psychiatry, 65, 1228-1234.
7. Chambers, C. D., Hernandez-Diaz, S., Van Marter, L. J. Werler, M. M., Louik, C., Jones, K. L., et al. (2006). Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. New England Journal of Medicine, 354, 579-587. (Pubitemid 43209105)
8. Chambers, C. D., Johnson, K. A., Dick, L. N., Felix, R. J., & Jones, K. L. (1996). Birth outcomes in pregnant women taking fluoxetine. New England Journal of Medicine, 335, 1010-1015.
9. Cohen, L. S., Altshuler, L. L., Harlow, B. L., Nonacs, R., Newport, D. J., Viguera, A. C., et. al. (2006). Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA, 296, 499-507. (Pubitemid 43200344)
10. Dharmananda, S. (2007). SSRI withdrawal procedure: Getting off antidepressants may be made easier. Retrieved on July 24, 2008, from www.itmonline.org/arts/ssri.htm
11. Eberhard-Gran, M., Eskild, A., & Opjordsmoen, S. (2006). Use of psychotropic medications in treating mood disorders during lactation: Practical recommendations. CNS Drugs, 20, 187-198.
12. Feighner, J. P., & Overo, K. (1999). Multicenter, placebo-controlled, fixeddose study of citalopram in moderate-to-severe depression. Journal of Clinical Psychiatry, 60, 824-830.
13. Finer, L. B. & Henshaw, S. K. (2006). Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspectives on Sexual and Reproductive Health, 38, 90-96.
14. Gavin, N. I., Gaynes, B. N., Lohr, K. N., Meltzer-Brody, S., Gartlehner, G., & Swinson, T. (2005). Perinatal depression: A systemic review of prevalence and incidence. Obstetrics & Gynecology, 106, 1071-1083.
15. Gillman, P. K. (2005). Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British Journal of Anaesthesia, 95, 434-441.
16. Gregorian, R. C., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002). Antidepressant-induced sexual dysfunction. Annals of Pharmacotherapy, 36, 1577-1589.
17. Hallberg, P., & Sjoblom, V. (2004). The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: A review and clinical aspects. Journal of Clinical Psychopharmacology, 25, 59-73.
18. Hale, T. W., Shum, S., & Grossberg, M. (2005). Fluoxetine toxicity in a breastfed infant. Clinical Pediatrics, 40, 681-684.
19. Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005). Epidemiology of major depressive disorder. Archives of General Psychiatry, 62, 1097-1106.
20. Hendrick V., Fukuchi, A., Altshuler, L., Widawski, M. Wertheimer, A., & Brunhuber, M. V. (2001). Use of sertraline, paroxetine and fluvoxamine by nursing women. British Journal of Psychiatry, 179, 163-166.
21. Horowitz, J. A., & Goodman, J. H. (2005). Identifying and treating postpartum depression. Journal of Obstetric, Gynecologic & Neonatal Nursing, 34, 264-273.
22. Kallen, B. (2004). Neonate characteristics after maternal use of antidepressants in late pregnancy. Archives in Pediatric and Adolescent Medicine, 158, 312-316.
23. Kessler R. C., Demler, O. Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., et al. (2005). Prevalence and treatment of mental disorders, 1990 to 2003. New England Journal of Medicine, 352, 2515-2523.
24. Louik, C., Lin, A. E., Werler, M. W., Hernandez-Diaz, S., & Mitchell, A. A. (2007). First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. New England Journal of Medicine, 356, 2675-2683.
25. Malm, H., Klaukka, T., & Neuvonen, P. J. (2005). Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstetrics & Gynecology, 106, 1289-1296.
26. Masand, P. S., & Gupta, S. (1999). Selective serotonin-reuptake inhibitors: An update. Harvard Review in Psychiatry, 7, 69-84.
27. Oberlander, T. F., Grunau, R. E., Fitzgerald, C., Ellwood, A. L., Misri, S., Rurak, D., et al. (2002). Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatric Research, 51, 443-453.
28. Piontek, C. M., Wisner, K. L., Perel, J. M., & Peindl, K. S. (2001). Serum fluvoxamine levels in breastfed infants. Journal of Clinical Psychiatry, 62, 111-113.
29. Ryan, D., Milis, L., & Misri, N. (2005). Depression during pregnancy. Canadian Family Physician, 51, 1087-1093.
30. Simon, G. E., Cunningham, M. L., & Davis, R. L. (2002). Outcomes of prenatal antidepressant exposure. American Journal of Psychiatry, 159, 2055-2061.
31. Stiskal, J. A., Kulin, N., Koren, G., Ho, T., & Ito, S. (2001). Neonatal paroxetine withdrawal syndrome. Archives of Disease in Childhood, 84, F134-F135.
32. Suppaseemanont, W. (2006). Depression in pregnancy: drug safety and nursing management. MCN The American Journal of Maternal Child Nursing, 31, 10-15.
33. Wogelius, P., Norgaard, M., Gislum, M., Pedersen, L., Munk, E., Mortensen, P., et al. (2006). Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformation. Epidemiology, 17, 701-704.
34. Zeskind, P. S., & Stephens, L. E. (2004). Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobiobehavior. Pediatrics,113, 368-375.